View in EDS

Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer.

Saved in:
Bibliographic Details
Title: Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer.
Authors: Foekens JA (AUTHOR), Look MP (AUTHOR), Peters HA (AUTHOR), van Putten WL (AUTHOR), Portengen H (AUTHOR), Klijn JG (AUTHOR), Foekens, J A1 (AUTHOR), Look, M P (AUTHOR), Peters, H A (AUTHOR), van Putten, W L (AUTHOR), Portengen, H (AUTHOR), Klijn, J G (AUTHOR)
Source: JNCI: Journal of the National Cancer Institute. 5/17/95, Vol. 87 Issue 10, p751-756. 6p.
Database: Academic Search Ultimate
Description
ISSN:00278874
DOI:10.1093/jnci/87.10.751